SCHEMBL17144982

SCHEMBL17144982

O=C(O)c1ccnc(CN2CCC(c3ccc(F)cc3)n3ccnc3C2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 8/20 0.47
▸ KDM5C P41229 1/20 0.47
▸ ACKR3 P25106 1/20 0.40
▸ KDM5A P29375 7/20 0.39
▸ KDM5B Q9UGL1 7/20 0.39
▸ KDM4A O75164 2/20 0.39
▸ SLC6A12 P48065 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ KDM2B Q8NHM5 2/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ PROKR1 Q8TCW9 1/20 0.34
▸ DRD4 P21917 1/20 0.34
▸ NR3C2 P08235 1/20 0.34
▸ SSTR5 P35346 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17144975 0.79 KDM4C (0.48) KDM4CKDM5CKDM5AKDM5BKDM4A
SCHEMBL17144777 0.75 KDM4C (0.58) KDM4CKDM5CKDM5AKDM5BKDM4A
SCHEMBL17144722 0.73 KDM4C (0.56) KDM4CKDM5CKDM5AKDM5BKDM4A
SCHEMBL19741663 0.73 KDM4C (0.56) KDM4CKDM5CKDM5AKDM5BKDM4A
SCHEMBL14814197 0.73 KDM4C (0.53) KDM4CKDM5CACKR3KDM5AKDM5B
SCHEMBL14825887 0.71 KDM4C (0.48) KDM4CKDM5CACKR3KDM5AKDM5B
SCHEMBL14825883 0.71 KDM4C (0.48) KDM4CKDM5CACKR3KDM5AKDM5B
SCHEMBL14813910 0.70 BCHE (0.55) KDM4CKDM5CALDH1A1LMNAOPRM1
SCHEMBL14825365 0.68 KDM4C (0.58) KDM4CKDM5CKDM5AKDM5BKDM4A
SCHEMBL2305288 0.68 KDM4C (0.76) KDM4CKDM5CKDM5AKDM5BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US claimed
EP-3126345-A1 INHIBITORS OF HISTONE DEMETHYLASES Gilead Sciences, Inc. (US) 2017-02-08 — — EP claimed
WO-2015153498-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS, APS (DK) 2015-10-08 — — WO claimed
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US disclosed
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM3A, KDM1A KDM4C 38/4885KDM5C 16/4885ACKR3 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback